MarketLens
Sign Up

United Therapeutics: CEO's Multi-Million Dollar Sales Signal Caution Amidst Bullish Consensus

3 months ago
SHARE THIS ON:

United Therapeutics: CEO's Multi-Million Dollar Sales Signal Caution Amidst Bullish Consensus

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•5 days ago

Eli Lilly's Biggest Shareholder Just Filed to Sell $347 Million of Stock

Eli Lilly's largest shareholder filed to sell ~$347M of stock, even as analysts keep raising price targets. The opposing signals leave investors weighing insider supply against bullish Street revision...
Stock News•1 week ago

This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

A Wall Street analyst turned bullish on United Therapeutics, upgrading the stock on Thursday. The change is part of a broader set of five analyst upgrades that day.
Stock News•2 months ago

United Therapeutics CEO Sells $5 Million of Shares. What Does This Mean for Investors?

United Therapeutics CEO sold 9,500 shares (~$5.0M) at ~$530.42 on July 27, 2026, a 1% reduction in holdings. Insider retains ~669,000 shares.

Breaking News

View All →

Top Headlines

View More →
Stock News•49 minutes ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Prediction: Alphabet Will Soar After Oct. 28

Stock News•1 hour ago

Alphabet (GOOGL) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Why Alphabet Inc. (GOOG) Dipped More Than Broader Market Today

Stock News•2 hours ago

OpenAI claims ex-employee brought confidential docs about ‘unreleased device' to Apple